Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Advances in Dermatology and Allergology
eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current Issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2025
vol. 42
 
Share:
Share:
Original paper

Relationship between allergic asthma and cerebrovascular accident: allergic asthma can increase recurrence of stroke

Shi Jinghua
1
,
Zhao Gaonian
1
,
Jiang Su
1

  1. Department of Rehabilitation Medicine, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Jiangsu, China
Adv Dermatol Allergol 2025; XLII (2): 150-155
Online publish date: 2024/12/02
Article file
- Relationship (3).pdf  [0.13 MB]
Get citation
 
 

Introduction

Asthma is a common, chronic respiratory disease which can result in persistent or episodic symptoms and limitation of airflow, and airway wall thickening [1]. The pathophysiology of the asthma is heterogeneous and complex, including different interactions happening at several scales, from genes to organs [2, 3]. Asthma causes different symptoms such as chest tightness, wheezing, cough, impaired lung function, acute asthma attack, and disturbs daily life [4]. About 300 million people suffer from asthma internationally, and the prevalence of asthma is increasing [5, 6]. Approximately up to 10% of asthma patients are reported to suffer from severe asthma [3]. This patient group has poor disease control and recurrent exacerbations in spite of treatment with mixed inhaled medication therapy [7]. It has been observed that there are other co-morbidities in asthma patients and asthma can increase the severity of those diseases or those diseases can increase the severity of asthma in patients and based on the severity of asthma, the prevalence of these diseases can increase [8]. It was confirmed that stroke can be more common in patients with respiratory diseases. So, there may be a marked interaction between asthma and stroke as asthma can be an independent risk factor for stroke, and severity of asthma exhibits a linear response of stroke progress [9, 10]. This evidence represents the basis for expansion of neuro-respiratory disorders, which emphasizes the significance of the interconnection between the central nervous system (CNS) and pulmonary systems for enhancing the management of patients [11, 12]. As the second leading cause of death stroke is the foremost cause of disability, with approximately 11% of all deaths. Stroke incidence is estimated to be 0.2% of the population yearly, with the mortality rate of 16.6% within the 1st month of ischemic stroke and nearly 50% of stroke patients suffer from disability [13]. Cerebrovascular disease mentions vasculature brain disorders which affect the blood stream of the related tissues. For better understanding of this disorder, the pathology of the cerebral vessels, and also the brain parenchyma and risk factors which may affect these structures must be known [14]. Stroke may affect life expectancy, emotion, mentality, and stroke-related disability makes survivors reduce their employability [15]. Approximately 34% of worldwide healthcare expenditure is related to the stroke. In recent decades in people aged under 65, the incidence of stroke has increased. Now, the risk of stroke in younger people has also been considered [16]. Therefore, scientists try to discover new risk factors for stroke. As mentioned asthma may be a possible risk factor for stroke. Chronic inflammation plays a significant role in stroke development [17]. Also, asthma as an inflammatory disease can play an important role in the possibility of stroke [18]. Previous studies reported the relationship between asthma and stroke, because the inflammatory nature of asthma can cause stroke and this has been documented in the mentioned research studies [19]. And now asthma can be introduced as an independent risk factor in the occurrence of stroke, although there are not enough findings in this regard.

Aim

Considering the importance of the emergence of possible risk factors for the occurrence of stroke and according to past research studies on the role of asthma in the development of stroke, the aim of the current study is to evaluate the relationship between allergic asthma and cerebrovascular accident in two different parts: the effect of stroke on pulmonary function (PF) of asthma patients and also the relationship of asthma and incidence of recurrent stroke.

Material and methods

Design

This is a prospective cohort study to observe pulmonary function changes during 6-month follow-up, conducted in the Affiliated Taizhou People's Hospital of Nanjing Medical University Hospital from February 2024 to August 2024. Adult patients suspected of having asthma were enrolled and asthma was diagnosed according to the criteria confirmed by the Global Initiative for Asthma (GINA). Also, stroke diagnosis was based on the World Health Organization definition, if patients experienced a sudden onset of sensory loss or weakness on one side of the body, sudden vision loss, or sudden speech loss.

Study population

In general, 120 patients who were matched for age and gender were included in the study in three groups. 40 patients with a history of controlled asthma who came to the treatment centre with a complaint of stroke were included in the study as the asthma stroke group, and 40 patients with a history of controlled asthma without stroke were included in the study as the control group with age and gender matching as the asthma non-stroke group. Also, 40 patients with no history of asthma with stroke complaints were included in the study and were considered as the non-asthma stroke group.

Inclusion and exclusion criteria

Inclusion criteria include having confirmed asthma and no history of rheumatic diseases, myocardial infarction, and malignancy. Also the age range was 18 to 65 years. We excluded patients who did not complete the follow-up tests, or died for reason other than stroke.

Study variables

Age, gender, height, weight, body mass index (BMI), and underlying disease like hypertension (HTN), diabetes (DM), and cardiovascular disease (CVD) were recorded. Pulmonary function tests (PFT), including forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), FEV1/FVC, and respiratory muscle function including maximal expiratory pressure (MEP) and maximal inspiratory pressure (MIP), exercise capacity by 6-minute walk test (6MWT) were conducted at the time of stroke and requested from patients documents up to 6 months before stroke/patients were requested to provide documents for up to 6 months before stroke. For the non-asthma stroke group only post stroke PFT was used. All tests were performed voluntarily.

Statistical analysis

The SPSS version 23.0 was used for all data analysis. Quantitative characteristics are expressed as mean ± SD, and qualitative data are reported in percentages. We used Mann-Whitney test for non-normally distributed data. For comparisons of the correlations, c2 and Fisher’s exact tests were used. P-value < 0.05 was considered as significant.

Results

The average age of the patients in the three groups shows that there is no significant difference between the ages of the patients (p = 0.28). Also, the average weight (p = 0.55), height (p = 0.45) and BMI (p = 0.44) of the patients of all three groups did not show any significant difference. Moreover, 50% of patients in each group were female (Table 1).

Table 1

Basic characteristics of patients

ParameterAsthma stroke groupAsthma non-stroke groupNon-asthma stroke groupP-value
Female gender50%50%50%1.0
Age55.55 ±1.9856.32 ±2.7355.82 ±1.810.28
Weight67.80 ±2.2568.07 ±2.0968.35 ±2.380.55
Height165.85 ±1.96166.32 ±1.681.65 ±1.690.45
BMI24.64 ±0.6124.61 ±0.8324.82 ±0.890.44

Pulmonary function and 6MWD changes in patients with asthma stroke and non-stroke asthma pre and post stroke

Our findings showed that in the asthma stroke group, pre stroke FVC (3.04 ±0.13 vs. 3.09 ±0.16, p = 0.16), FEV1 (2.68 ±0.15 vs. 2.69 ±0.17, p = 0.78), FEV1/FVC (0.88 ±0.03 vs. 0.87 ±0.02, p = 0.13), MIP (74.05 ±5.36 vs. 75.55 ±4.32, p = 0.17), MEP (88.30 ±3.65 vs. 89.42 ±4.57, p = 0.22) and 6MWT (446.32 ±47.56 vs. 448.47 ±35.42, p = 0.81) were not significantly different from the asthma non-stroke group.

Examining the post stroke intra-group changes showed that there was no significant difference in any of the variables such as FEV1 (p = 0.11), FVC (p = 0.18), FEV1/FVC (p = 0.59), MIP (p = 0.72), MEP (p = 0.17) in the asthma non-stroke group but only 6MWT (p = 0.03) showed a significant decrease. But in the asthma stroke group, post stroke FVC (3.04 ±0.13 vs. 2.58 ±0.15, p = 0.006), FEV1 (2.68 ±0.15 vs. 2.01 ±0.12, p = 0.02), FEV1/FVC (0.88 ±0.03 vs. 0.77 ±0.02, p = 0.001), MIP (74.05 ±5.36 vs. 56.57 ±3.83, p = 0.001), MEP (88.30 ±3.65 vs. 71.42 ±3.98, p = 0.001) and 6MWT (446.32 ±47.56 vs. 338.62 ±28.85, p = 0.001) were significantly decreased in comparison to those before stroke (Table 2).

Table 2

Pulmonary function and 6MWD changes in patients with asthma stroke and non-stroke asthma

ParameterAsthma stroke groupAsthma non-stroke groupP-value
FVCPre3.04 ±0.133.09 ±0.160.16
Post2.58 ±0.153.03 ±0.160.001
P-value0.0060.11
FEV1Pre2.68 ±0.152.69 ±0.170.78
Post2.01 ±0.122.65 ±0.150.001
P-value0.020.18
FEV1/FVCPre0.88 ±0.030.87 ±0.020.13
Post0.77 ±0.020.87 ±0.050.001
P-value0.0010.59
MIPPre74.05 ±5.3675.55 ±4.320.17
Post56.57 ±3.8365.25 ±4.930.001
P-value0.0010.72
MEPPre88.30 ±3.6589.42 ±4.570.22
Post71.42 ±3.9888.65 ±3.270.001
P-value0.0010.17
6MWDPre446.32 ±47.56448.47 ±35.420.81
Post338.62 ±28.85440.77 ±42.090.001
P-value0.0010.03

Comparison of PF, 6MWD and stroke recurrence in patients with asthma stroke and non-asthma stroke

There was no significant difference in the prevalence of DM (43.5% vs. 47.5%, p = 0.64), HTN (52.5% vs. 57.5%, p = 0.65) and CVD (37.5% vs. 32.5%, p = 0.64) respectively between the asthma stroke and non-asthma stroke groups.

Also, no significant difference was found between the type of stroke in two groups; in the asthma stroke group, in 80% ischemic stroke and 20% haemorrhagic stroke was seen, and in the non-asthma stroke group, in 75% ischemic stroke and 25% haemorrhagic stroke was reported (p = 0.59).

Also, stroke recurrence was 32.5% in the asthma stroke group and 12.5% in the non-asthma stroke group, which was significantly higher in the asthma stroke group (p = 0.001).

Comparison of pulmonary function of patients after stroke showed that all FVC (2.58 ±0.15 vs. 3.36 ±0.14, p = 0.001), FEV1 (2.01 ±0.12 vs. 2.73 ±0.16, p = 0.001), FEV1/FVC (0.77 ±0.02 vs. 0.81 ±0.03, p = 0.001), MIP (56.57 ±3.83 vs. 70.62 ±2.77, p = 0.001), MEP (71.42 ±3.98 vs. 85.97 ±2.31, p = 0.001) and 6MWT (338.62 ±28.85 vs. 385.67 ±29.82, p = 0.001) in the asthma stroke group were significantly decreased in comparison to the non-asthma stroke group (Table 3).

Table 3

Comparison of PF, 6MWD and stroke recurrence in patients with asthma stroke and non-asthma stroke

ParameterAsthma stroke groupNon-asthma stroke groupP-value
DM17 (42.5%)19 (47.5%)0.64
HTN21 (52.5%)23 (57.5%)0.65
CVD15 (37.5%)13 (32.5%)0.64
Type of stroke (I/H)32 (80%)/8 (20%)30 (75%)/10 (25%)0.59
Recurrence13 (32.5%)5 (12.5%)0.03
FVC2.58 ±0.153.36 ±0.140.001
FEV12.01 ±0.122.73 ±0.160.001
FEV1/FVC0.77 ±0.020.81 ±0.030.001
MIP56.57 ±3.8370.62 ±2.770.001
MEP71.42 ±3.9885.97 ±2.310.001
6MWT338.62 ±28.85385.67 ±29.820.001

Discussion

The present study showed that after stroke in asthmatic patients, pulmonary function was significantly reduced and compared to asthmatic non-stroke patients, all FVC, FEV1, FEV1/FVC, MIP, MEP and 6MWT were significantly reduced. Also, compared to non-asthmatic stroke patients, all of above factors have been significantly decreased in asthmatic stroke patients. But these findings have not been clear in past studies, because in some studies, a significant difference has been reported between the occurrence of stroke and a decrease in pulmonary function, and in some other studies, this difference was not significant, so this issue is still controversial. After stroke respiratory muscles become weaker in addition to chest muscles, which decreases exercise capacity and produces problems in performing daily life activities [20, 21]. Previous research studies showed that decreased respiratory muscle activity may reduce core stability, which is essential for normal balance and mobility [22, 23]. Lista-Paz et al. showed that stroke patients had significantly reduced lung volumes, also 6MWD was reported to be weakly correlated with inspiratory reserve volume and peak inspiratory flow [24]. In another study the authors reported lower values of MIP and MEP in survivors and a positive correlation between 6MWT and MIP [25]. Also, Ezeugwu et al. reported that compared to the controls, the stroke patients had significantly reduced values for FEV1, FVC and PEF [26]. The results of Jandt et al. also confirm a reduction in MEP and MIP in stroke patients, and showed a positive significant correlation between MEP and trunk control [27].

Another finding of the present study is that the prevalence of recurrent stroke in asthmatic stroke patients is higher than in stroke patients without asthma. This finding has been less investigated in other studies and has had conflicting results and is still controversial. The chronic inflammatory nature of asthma speeds up the atherosclerosis process, which may develop stroke progress [28]. Asthma and stroke have various common risk factors, as well as/and so have aging, air pollution, smoking, and stress. Therefore, the relationship between asthma and stroke, affected by confounding factors. Previous research studies showed that asthma was an independent risk factor for stroke. Asthma induced endothelial damage, enhanced progression of atherosclerosis, and initiated thrombosis, by reducing lung function and hypoxemia [29, 30]. Allergens can cause activation of inflammatory pathways in the asthmatic patient’s lungs, which is aggravated by the platelets pro-inflammatory effects and reduce cyto-protective response [31]. Asthma can exacerbate thrombosis of cerebral vessels and elevate the vulnerability of the cerebral vessels, thus cause a stroke risk in patients. We found that stroke recurrence was 32.5% in the asthma stroke group and 12.5% in the non-asthma stroke group, which was significantly higher in the asthma stroke group (p = 0.001). In contrast with our findings, Kim et al. [32] showed that none of the asthma patients reported elevated HRs for stroke and asthma did not promote the risk of stroke. But in line with the current study, Cepelis et al. [33] by evaluating 58,712 adult patients reported that active asthma was associated with a modest elevated relative risk of stroke in smokers and also in males. Also, Onufrak et al. [34] showed that females with adult asthma experienced a 2-fold increase in the risk of stroke in the America. Moreover, Chung et al. in a cohort study using health claim codes showed a 1.37-fold higher risk of stroke in asthma patients [35]. Another study by Iribarren et al. [36] showed that asthma is associated with a 1.2-fold hazard of stroke for adults. Also Wen et al. [37] reported in a meta-analysis study which included 5 articles with 524,637 participants, that asthma is associated with a significantly elevated risk of stroke. Finally, the results of the present study and the review of other studies show that asthma is an independent risk factor for stroke in patients.

Conclusions

The results of the present study showed that in asthmatic people, stroke can significantly reduce lung function by decreasing FVC, FEV1, and FEV1/FVC. Also MIP and MEP are reduced, which shows a decrease of respiratory muscle function and 6MWT were significantly as test for exercise capacity, decrease in asthmatic patients after stroke, likewise asthma can increase the risk of recurrence of stroke in asthmatic stroke patients as an independent risk factor.

Ethical approval

Not applicable.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Papi A, Blasi F, Canonica GW, et al. Treatment strategies for asthma: reshaping the concept of asthma management. Allergy Asthma Clin Immunol 2020; 16: 75.

2 

Losol P, Choi JP, Kim SH, Chang YS. The role of upper airway microbiome in the development of adult asthma. Immune Network 2021; 21: e19.

3 

Hammad H, Lambrecht BN. The basic immunology of asthma. Cell 2021; 184: 1469-85.

4 

Corren J, Menzies-Gow A, Chupp G, et al. Efficacy of tezepelumab in severe, uncontrolled asthma: pooled analysis of the PATHWAY and NAVIGATOR clinical trials. Am J Respir Crit Care Med 2023; 208: 13-24.

5 

Nanda A, Wasan AN. Asthma in adults. Med Clin 2020; 104: 95-108.

6 

Kupczyk M, Haahtela T, Cruz AA, Kuna P. Reduction of asthma burden is possible through National Asthma Plans. Allergy 2010; 65: 415-9.

7 

Brightling CE, Nair P, Cousins DJ, et al. Risankizumab in severe asthma – a phase 2a, placebo-controlled trial. N Engl J Med 2021; 385: 1669-79.

8 

Porsbjerg C, Menzies-Gow A. Co-morbidities in severe asthma: clinical impact and management. Respirology 2017; 22: 651-61.

9 

Chung WS, Lin CL, Chen YF, et al. Increased stroke risk among adult asthmatic patients. Eur J Clin Investig 2014; 44: 1025-33.

10 

Corlateanu A, Stratan I, Covantev S, et al. Asthma and stroke: a narrative review. Asthma Res Pract 2021; 7: 3.

11 

Holla VV, Prasad S, Pal PK. Neurological effects of respiratory dysfunction. Handb Clin Neurol 2022; 189: 309-29.

12 

Fung TK, Lau BW, Ngai SP, Tsang HW. Therapeutic effect and mechanisms of essential oils in mood disorders: interaction between the nervous and respiratory systems. Int J Mol Sci 2021; 22: 4844.

13 

Alloubani A, Nimer R, Samara R. Relationship between hyperlipidemia, cardiovascular disease and stroke: a systematic review. Curr Cardiol Rev 2021; 17: e051121189015.

14 

Engelhardt E. Apoplexy, cerebrovascular disease, and stroke: historical evolution of terms and definitions. Dementia Neuropsychol 2017; 11: 449-53.

15 

Hu J, Xu Y, He Z, et al. Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis. Oncotarget 2018; 9: 2752.

16 

Rochmah TN, Rahmawati IT, Dahlui M, et al. Economic burden of stroke disease: a systematic review. Int J Environ Res Public Health 2021; 18: 7552.

17 

Zhu H, Zhang Y, Zhong Y, et al. Inflammation-mediated angiogenesis in ischemic stroke. Front Cell Neurosci 2021; 15: 652647.

18 

Cheng W, Bu X, Xu C, et al. Higher systemic immune-inflammation index and systemic inflammation response index levels are associated with stroke prevalence in the asthmatic population: a cross-sectional analysis of the NHANES 1999-2018. Front Immunol 2023; 14: 1191130.

19 

Wen LY, Ni H, Li KS, et al. Asthma and risk of stroke: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2016; 25: 497-503.

20 

Kubo H, Nozoe M, Yamamoto M, et al. Recovery process of respiratory muscle strength in patients following stroke: a pilot study. Phys Ther Res 2020; 23: 123-31.

21 

Fabero-Garrido R, Del Corral T, Angulo-Díaz-Parreño S, et al. Respiratory muscle training improves exercise tolerance and respiratory muscle function/structure post-stroke at short term: a systematic review and meta-analysis. Ann Phys Rehabil Med 2022; 65: 101596.

22 

Lee K, Cho JE, Hwang DY, Lee W. Decreased respiratory muscle function is associated with impaired trunk balance among chronic stroke patients: a cross-sectional study. Tohoku J Exp Med 2018; 245: 79-88.

23 

Park HY, Kwon OY, Yi CH, et al. Respiratory parameters as predictors of balance and gait ability in patients with stroke at discharge. Int J Environ Res Public Health 2023; 20: 7098.

24 

Lista-Paz A, Kuisma R, Canosa JL, et al. Pulmonary function in patients with chronic stroke compared with a control group of healthy people matched by age and sex. Physiother Theory Pract 2023; 39: 918-26.

25 

Paz AL, Doniz LG, García SO, et al. Respiratory muscle strength in chronic stroke survivors and its relation with the 6-minute walk test. Arch Phys Med Rehab 2016; 97: 266-72.

26 

Ezeugwu VE, Olaogun M, Mbada CE, Adedoyin R. Comparative Lung function performance of stroke survivors and age-matched and sex-matched controls. Physiother Res Int 2013; 18: 212-9.

27 

Jandt SR, da Sil Caballero RM, Junior LA, Dias AS. Correlation between trunk control, respiratory muscle strength and spirometry in patients with stroke: an observational study. Physiother Res Int 2011; 16: 218-24.

28 

Gurgone D, McShane L, McSharry C, et al. Cytokines at the interplay between asthma and atherosclerosis? Front Pharmacol 2020; 11: 166.

29 

Tuleta I, Skowasch D, Aurich F, et al. Asthma is associated with atherosclerotic artery changes. PLoS One 2017; 12: e0186820.

30 

Wee JH, Park MW, Min C, et al. Association between asthma and cardiovascular disease. Eur J Clin Investig 2021; 51: e13396.

31 

Ramos SM, Silva DM, Buchaim DV, et al. Evaluation of respiratory muscular strength compared to predicted values in patients with stroke. Int J Environ Res Public Health 2020; 17: 1091.

32 

Kim SY, Lim H, Lim JS, Choi HG. Analysis of the relationship between adult asthma and stroke: a longitudinal follow-up study using the Korean national sample cohort. BioMed Res Int 2019; 2019: 8919230.

33 

Cepelis A, Brumpton BM, Laugsand LE, et al. Asthma, asthma control and risk of ischemic stroke: the HUNT study. Respir Med X 2020; 2: 100013.

34 

Onufrak SJ, Abramson JL, Austin HD, et al. Relation of adult-onset asthma to coronary heart disease and stroke. Am J Cardiol 2008; 101: 1247-52.

35 

Chung WS, Lin CL, Chen YF, et al. Increased stroke risk among adult asthmatic patients. Eur J Clin Investig 2014; 44: 1025-33.

36 

Iribarren C, Tolstykh IV, Miller MK, et al. Adult asthma and risk of coronary heart disease, cerebrovascular disease, and heart failure: a prospective study of 2 matched cohorts. Am J Epidemiol 2012; 176: 1014-24.

37 

Wen LY, Ni H, Li KS, et al. Asthma and risk of stroke: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis 2016; 25: 497-503.

Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.